Refreshingly Adaptable CDMO 2018-05-22T12:23:20+00:00

BioVectra logo

Microbial Fermentation

BioVectra is an industry leader in microbial fermentation, with 64,000 L of fermentation capacity.

Types of Drug Products:

  • Small molecules
  • Proteins
  • Enzymes
  • Antibody fragments
  • Peptides
Range of Microbes:

  • Filamentous bacteria
  • Marine based bacteria
  • Fungal fermentation
  • E. Coli
Downstream Processing:

  • Centrifugations
  • Lysis
  • Purification
  • UF/DF
  • Synthetic chemistry

Learn more

BioVectra logo

Complex Chemistry

BioVectra’s complex chemistry expertise includes:

  • Wide-ranging synthetic chemistry capabilities
  • Normal phase and reversed phase purification capabilities
  • Potent chemistry (occupational exposure limit levels of < 20 ng/m3)
  • Small molecule capture methods supporting downstream processing
  • Instrumental tools for reaction design and monitoring

Learn more

BioVectra logo

High Potency APIs

BioVectra’s fermentation and chemical processing suites are equipped to handle the development and cGMP scale-up of High Potency APIs (HPAPIs). We have experience handling potent substances with occupational exposure limit (OEL) levels of < 20 ng/m3 (Safebridge Band 3 and 4).

Learn more

BioVectra logo


Our distinct Microbial Biologics facility in Windsor, Nova Scotia, Canada is equipped to work with a range of biosafety level one (BSL-1) expression systems, including

  • E. Coli
  • Pichia Pastoris
  • Saccharomyces Cerevisiae

Learn more

BioVectra logo

Process & Analytical Development

Process and analytical development at BioVectra includes:

  • Pre-clinical, clinical phase I-III and commercial
  • Technology transfer of process and methods
  • Process scale-up from milligram to metric ton quantities
  • Analytical method development and validation
  • Phase appropriate cGMP and Quality by Design (QbD)
  • Life-cycle management approach

Learn more

BioVectra logo

Drug Development

BioVectra’s drug development activities capitalize on our experience, expertise and capabilities, with specific focus on:

  • Mircobial fermentation
  • Complex chemical synthesis
  • Complex IV and IM formulations
    • Nanoparticulate formulations, controlled release, high potency APIs

Learn more

BioVectra logo


BioVectra is a leading supplier of high quality reagents to the pharmaceutical and biotechnology industries. Our reagents include:

Bioprocessing Reagents: Diagnostic Reagents: Molecular Biology Reagents: MPEG Reagents:
  • DTT
  • DTE
  • DHAA
  • PEP-K
  • pNPP-Na
  • GPNA
  • X-Gal
  • BCIP-Na
  • XTT
  • Maleimides
  • Propionaldehydes
  • Amines

Learn more

What’s New

BioVectra and TUBE Biopharmaceuticals Sign Exclusive License for Microbial Fermentation Technology to Manufacture Tubulysins

BioVectra and TUBE Biopharmaceuticals Sign Exclusive License for Microbial Fermentation Technology to Manufacture Tubulysins 16/07/18 – CHARLOTTETOWN, Prince Edward Island, Canada – Today, BioVectra Inc., a global Contract Development and Manufacturing Organization (CDMO) with [...]



Schedule a Meeting!


Facilitiy Overview

  • 110,000 Square feet manufacturing facility space
  • 50,000 L of chemical reactor space (20 L to 18,000 L)
  • 64,000 L of fermentation reactor space (30 L to 17,000 L)